Public Employees Retirement Association of Colorado boosted its stake in ICU Medical Inc. (NASDAQ:ICUI) by 112.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,680 shares of the company’s stock after buying an additional 31,000 shares during the period. Public Employees Retirement Association of Colorado’s holdings in ICU Medical were worth $6,616,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Bayesian Capital Management LP raised its stake in ICU Medical by 0.3% in the first quarter. Bayesian Capital Management LP now owns 2,150 shares of the company’s stock valued at $224,000 after buying an additional 7 shares during the last quarter. Eqis Capital Management Inc. increased its stake in ICU Medical by 0.7% in the second quarter. Eqis Capital Management Inc. now owns 2,509 shares of the company’s stock worth $283,000 after buying an additional 18 shares during the last quarter. M&T Bank Corp increased its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares during the last quarter. Capstone Asset Management Co. increased its stake in ICU Medical by 6.9% in the second quarter. Capstone Asset Management Co. now owns 4,868 shares of the company’s stock worth $549,000 after buying an additional 315 shares during the last quarter. Finally, Smith Asset Management Group LP increased its stake in ICU Medical by 2.3% in the second quarter. Smith Asset Management Group LP now owns 25,782 shares of the company’s stock worth $2,907,000 after buying an additional 590 shares during the last quarter. 89.50% of the stock is currently owned by institutional investors and hedge funds.
Shares of ICU Medical Inc. (NASDAQ:ICUI) traded down 1.23% during mid-day trading on Tuesday, hitting $144.09. 269,529 shares of the stock were exchanged. The company has a 50-day moving average of $130.70 and a 200 day moving average of $114.79. The stock has a market cap of $2.32 billion, a PE ratio of 42.91 and a beta of 0.37. ICU Medical Inc. has a one year low of $85.56 and a one year high of $152.69.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Monday, August 8th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.10. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The business had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. During the same period in the previous year, the business posted $0.97 earnings per share. The business’s revenue was up 15.4% compared to the same quarter last year. On average, equities analysts predict that ICU Medical Inc. will post $4.54 earnings per share for the current year.
A number of research firms have commented on ICUI. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $141.00 price objective for the company in a report on Wednesday, September 21st. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 price objective (up previously from $115.00) on shares of ICU Medical in a report on Thursday, August 11th.
In related news, VP Steven Riggs sold 44,739 shares of the business’s stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $121.78, for a total transaction of $5,448,315.42. Following the sale, the vice president now owns 675 shares of the company’s stock, valued at $82,201.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard Md Sherman sold 1,500 shares of the business’s stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $140.60, for a total transaction of $210,900.00. Following the sale, the director now directly owns 70,699 shares in the company, valued at approximately $9,940,279.40. The disclosure for this sale can be found here. Corporate insiders own 15.90% of the company’s stock.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.